The Misuse of Drugs (Amendment) Regulations 1996

• Citation: S.I. 1996/1597
• Sections: 2

Section 1

These Regulations may be cited as the Misuse of Drugs (Amendment) Regulations 1996 and shall come into force on 1st September 1996.

Section 2

(1) The Misuse of Drugs Regulations 1985 shall be amended as follows.

(2) In that part of the index to the regulations headed “SCHEDULES”, after the entry in respect of SCHEDULE 3, there shall be inserted—

SCHEDULE 4 Part I Controlled drugs excepted from the prohibition on possession when in the form of a medicinal product; excluded from the application of offences arising from the prohibition on importation and exportation when imported or exported in the form of a medicinal product by any person for administration to himself; and subject to the requirements of regulations 22, 23, 25 and 26.

and after the existing words “SCHEDULE 4”there shall be inserted the words “Part II”.

(3) In regulation 4(1), there shall be substituted for the words “Schedules 4 and 5”the words “Part II of Schedule 4 and Schedule 5”.

(4) After regulation 4(1), there shall be inserted—

(1A) The application of section 3(1) of the Act in so far as it creates an offence and of sections 50(1) to (4), 68(2) and (3) or 170 of the Customs and Excise Management Act 1979 in so far as they apply in relation to a prohibition or restriction on importation or exportation having effect by virtue of section 3 of the Act, are hereby excluded in the case of importation or exportation by any person for administration to himself of any drug specified in Part I of Schedule 4 which is contained in a medicinal product.

(5) After Schedule 3 there shall be inserted—

CONTROLLED DRUGS EXCEPTED FROM THE PROHIBITION ON POSSESSION WHEN IN THE FORM OF A MEDICINAL PRODUCT; EXCLUDED FROM THE APPLICATION OF OFFENCES ARISING FROM THE PROHIBITION ON IMPORTATION AND EXPORTATION WHEN IMPORTED OR EXPORTED IN THE FORM OF A MEDICINAL PRODUCT BY ANY PERSON FOR ADMINISTRATION TO HIMSELF; AND SUBJECT TO THE REQUIREMENTS OF REGULATIONS 22, 23, 25 AND 26.

(1) The following substances, namely—

Atamestane

Bolandiol

Bolasterone

Bolazine

Boldenone

Bolenol

Bolmantalate

Calusterone

4-Chloromethandienone

Clostebol

Drostanolone

Enestebol

Ethyloestrenol

Epitiostanol

Fluoxymesterone

Formebolone

Furazabol

Mebolazine

Mepitiostane

Mesabolone

Mestanolone

Mesterolone

Methandienone

Methandriol

Methenolone

Methyltestosterone

Metribolone

Mibolerone

Nandrolone

Norboletone

Norclostebol

Norethandrolone

Ovandrotone

Oxabolone

Oxandrolone

Oxymesterone

Oxymetholone

Prasterone

Propetandrol

Quinbolone

Roxibolone

Silandrone

Stanolone

Stanozolol

Stenbolone

Testosterone

Thiomesterone

Trenbolone

(2) Any compound (not being Trilostane or a compound for the time being specified in paragraph 1 of this Part of this Schedule) structurally derived from 17-hydroxyandrostan-3-one or from 17-hydroxyestran-3-one by modification in any of the following ways, that is to say,

(a) by further substitution at position 17 by a methyl or ethyl group;

(b) by substitution to any extent at one or more of positions 1, 2, 4, 6, 7, 9, 11 or 16, but at no other position;

(c) by unsaturation in the carbocyclic ring system to any extent, provided that there are no more than two ethylenic bonds in any one carbocyclic ring;

(d) by fusion of ring A with a heterocyclic system.

(3) Any substance which is an ester or ether (or, where more than one hydroxyl function is available, both an ester and an ether) of a substance specified in paragraph 1 or described in paragraph 2 of this Part of this Schedule.

(4) The following substances, namely—

Chorionic Gonadotrophin ( HCG )

Clenbuterol

Non-human chorionic gonadotrophin

Somatotropin

Somatrem

Somatropin

(5) Any stereoisomeric form of a substance specified or described in any of paragraphs 1 to 4 of this Part of this Schedule.

(6) Any salt of a substance specified or described in any of paragraphs 1 to 5 of this Part of this Schedule.

(7) Any preparation of other product containing a substance or product specified or described in any of paragraphs 1 to 6 of this Part of this Schedule, not being a preparation specified in Schedule 5.

(6) The existing Schedule 4 shall be renamed “SCHEDULE 4 PART II ”.